- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04677023
Evaluation of Organically Modified Ceramic Resin Composite Versus Bulkfill Resin in Proximal Posterior Cavities
December 21, 2020 updated by: safinaz hussien fahmy hassan, Cairo University
Clinical Evaluation of Organically Modified Ceramic Resin Composite Versus Conventional Bulkfill Resin Composite in Proximal Compound Posterior Restorations: Randomized Clinical
In patients with compound posterior proximal cavities, will the use of organically modified ceramic resin composite restorative material have similar clinical performance to conventional bulk fill resin composite, evaluation of restorations will be done at baseline,six and twelve months using World Dental Federation FDI criteria.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The study will be conducted in the clinic of Conservative Dentistry Department, Faculty of Dentistry, Cairo University; the operator in charge Safinaz Hussien ,The subjects fulfilling the eligibility criteria of the trial will be selected from the regular attendees at the clinic of Conservative Dentistry Department, Faculty of Dentistry, Cairo University.Patient examination will be done including medical history, dental history, extra-oral examination and intra-oral examination.
A periapical radiograph will be taken prior to restorative procedures to assess the degree of approximation of caries to pulp, intactness of lamina dura and/or presence of any periapical radiolucency to exclude the case.The field of operation will be isolated with the application of a rubber dam if possible.
Otherwise, cotton rolls and the saliva ejector will be used for moisture control.
For cavity preparation, local anesthetic (Mepecaine-L, Alexandria Company, Egypt) solution will be administrated to control patient discomfort during the procedure.The cavities will be prepared by using cylindrical #314 (Komet®, Germany) in a high speed handpiece (Sirona, Germany) rotating at high speed with copious coolant.
Remaining soft caries -if present- will be removed using sharp excavator (Maillefer, Dentsuply, Switzerland).After the cavity preparation is finished, it will be thoroughly air-water cleaned.
The bonding system; FuturabondU(Voco, Germany) will be applied according to the following instructions recommended by the manufacturer: Futurabond M+ will be applied to prepared tooth structure and cured for 20 seconds using Elipar™ S10 LED curing light (3M ESPE, St Paul, MN, USA) with light intensity of 1200 mW/cm2.
The prepared cavities will be restored with Admira fusion X--tra® bulk (VOCO, Cuxhaven in layers that are a maximum of 4 mm thick then cured for 20 seconds using usingElipar™ S10 LED curing light (3M ESPE, St Paul, MN, USA) with light intensity of 1200 mW/cm2.
and for the control group cavities will be restored with GrandioSO x-tra(VOCO, Cuxhaven) in layers that are a maximum of 4 mm thick then cured for 20 seconds using usingElipar™ S10 LED curing light (3M ESPE, St Paul, MN, USA) with light intensity of 1200 mW/cm2.
Study Type
Interventional
Enrollment (Anticipated)
22
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients aging ≥18 years.
- Patients with a high level of oral hygiene.
- Patients having at least 1or 2 posterior teeth in occlusion.
- Patients with good likelihood of recall availability.
Tooth inclusion:
- Permanent premolars or molars.
- Moderate to deep compound class II cavities.
- Primary carious lesions.
- Vital with positive reaction to cold thermal stimulus.
- Well-formed and fully-erupted in normal functional occlusion with natural antagonist and adjacent teeth.
Exclusion Criteria:
- Participants with general/systemic illness.
- Pregnant or lactating females.
- Concomitant participation in another research study.
- Inability to comply with study procedures.
- Heavy bruxism habits.
- Last experience with allergic reactions against any components of the used materials.
- Patients receiving orthodontic treatment.
Tooth exclusion:
- Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
- Non-vital teeth.
- Secondary carious lesions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Admira fusion X--tra® bulk
The special ORMOCER® compound molecules in Admira Fusion x-tra reduce the volume shrinkage to an extremely low level (1.25 % by volume) in conjunction with very low shrinkage stress (3.87 MPa).
Admira Fusion x-tra is the bulk fill version of Admira Fusion.
This means that this restorative material can be applied in layers of up to 4 mm and then reliably cured.
This makes placing posterior restorations particularly quick and economical.
The universal shade U further simplifies handling, as it provides aesthetic results by adapting, chameleon-like, to the surrounding dental substance
|
he prepared cavities will be restored with Admira fusion X-tra®️ bulk (VOCO, Cuxhaven, Germany) in layers that are a maximum of 4 mm thick then cured for 20 seconds using usingElipar™️ S10 LED curing light (3M ESPE, St Paul, MN, USA) with light intensity of 1200 mW/cm2.
|
OTHER: GrandioSO x-tra® bulk
a nano-hybrid composite which is in a class of its own.
It is distinguished by outstanding handling and excellent physical properties, modelled on the natural tooth.its the packable bulk fill material for the highest standards in durability and aesthetics.GrandioSO x-tra has outstanding surface hardness, at 223 MHV, which is closer to natural tooth enamel, compared with other bulk fill composites.
Because of this, GrandioSO x-tra ensures restorations which are abrasionresistant and dimensionally stable over the long term.
In addition to the surface hardness, reliable curing is very important when larger increments are used.
Here as well, GrandioSO x-tra achieves an outstanding result and, at the 219 MHV measured at a depth of 4 mm, it even significantly exceeds the values measured for other bulk fill composites at the surface.
|
The prepared cavities will be restored with GrandioSO X-tra (VOCO, Cuxhaven, Germany) in layers that are a maximum of 4 mm thick then cured for 20 seconds using using Elipar™️ S10 LED curing light (3M ESPE, St Paul, MN, USA) with light intensity of 1200 mW/cm2.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fracture
Time Frame: 24 months
|
Fracture of material visually inspected and evaluated using FDI probe and then classified accordingly
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
color match
Time Frame: 24 months
|
Esthetic visually inspected and evaluated using FDI probe and then classified
|
24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
secondary caries
Time Frame: 24 months
|
Biological properties: visually inspected and evaluated using FDI probe and then classified accordingly
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 1, 2021
Primary Completion (ANTICIPATED)
January 1, 2022
Study Completion (ANTICIPATED)
February 1, 2022
Study Registration Dates
First Submitted
September 15, 2020
First Submitted That Met QC Criteria
December 15, 2020
First Posted (ACTUAL)
December 21, 2020
Study Record Updates
Last Update Posted (ACTUAL)
December 23, 2020
Last Update Submitted That Met QC Criteria
December 21, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 88960
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
expecting to have all the data by October 2022
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proximal Caries
-
Universidad Rey Juan CarlosRecruitingInitial Proximal CariesSpain
-
DMG Dental Material Gesellschaft mbHOregon Health and Science University; Dep. Conservtive Dentistry, Periodontology...Withdrawn
-
Izmir Katip Celebi UniversityCompletedProximal CariesTurkey
-
Cairo UniversityCompleted
-
University of TennesseeActive, not recruitingProximal Muscle Strength | Proximal Muscle LengtheningUnited States
-
University of TromsoNorwegian Public dental health serviceCompletedReversible Pulpitis | Mature Teeth | Proximal Caries | Carious Exposure | Human Permanent First and Second Molars | Healthy PulpLithuania, Norway
-
Cairo UniversityCompleted
-
Synthes GmbHCompletedClosed Proximal Tibial Fracture Schatzker I - VI | Closed Proximal Tibial Fracture AO-OTA 41 | Closed Proximal Tibial Fracture AO-OTA 42Korea, Republic of
-
Vidacare CorporationUnknownProximal Humerus Intraosseous Vascular AccessUnited States
-
Cairo UniversityNot yet recruiting
Clinical Trials on Admira fusion X--tra® bulk
-
Mansoura UniversityCompletedA 2-year Clinical Impact of Bulk-fill Low-viscosity Resin Composite Liners in Class II Restorations.Dental Caries Class IIEgypt
-
Hacettepe UniversityActive, not recruiting
-
Izmir Katip Celebi UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityActive, not recruitingClinical Significance of Thermo-Viscous CompositeEgypt
-
Cairo UniversityRecruiting
-
Nuh Naci Yazgan UniversityTC Erciyes UniversityCompleted
-
Cairo UniversityCompleted